GSK's Influenza Vaccine Receives FDA Approval for Expanded Indication
The influenza vaccine can now be used to protect recommended persons aged 6 months and older.
Read More
FDA Approves Clinician Programmer for Medtronic SynchroMed II for Pain, Severe Spasticity
The newly approved system is an alternative to systemic opioids for patients.
Lyndra Announces Feasibility Study of Oral Once-Weekly HIV Drug
The study demonstrated proof-of-concept, demonstrating a sustained delivery system of 3 highly-potent antiretroviral therapies and drug-polymer matrices.
AbbVie's Upadacitinib Granted Breakthrough Therapy by FDA
Clear or mostly clear skin was achieved by 50/31/14% of patients receiving 30/15/7.5 mg doses of upadacitinib, compared to 2% of patients receiving placebo.
Sean Ianchulev, MD, MPH: Microinterventional Cataract Fragmentation
Dr. Ianchulev discusses his breakthrough technology, miLOOP, that will revolutionize the way cataract surgery is performed and how doctors fragment the lens.
Dietary Trehalose Enhances Clostridium Difficile Virulence
The increasing frequency and severity of healthcare-associated outbreaks of C. difficile have been linked to trehalose.
Preclinical Study Suggests Modified T-cells May Fight HIV
Findings could lead to the development of an approach allowing for a safe, lifelong immunity to HIV.
Paul P. Doghramji, MD, FAAFP: Challenges in Major Depressive Disorder
Paul P. Doghramji, MD, FAAFP discussed important issuess in addressing depressive disorder, along with the challenges in treating patients.
Evidence Supports HIV Screening in Young Adults
A study indicates that 25 is an ideal single HIV screening test age, among those without risk factors.
FDA Approves Aeterna Zentaris' Macimorelin Growth Hormone Deficiency Test
Findings indicated that Macrilen stimulated the pituitary gland to produce the growth hormone more effectively than the ITT.
Upadacitinib Shows Positive Rheumatoid Arthritis Study Results
The monotherapy resulted in LDA by week 14 in both the 15 mg (45%) and 30 mg (53%) groups.
Flu Shot is Safe for Those with Egg Allergies
According to 28 studies, there is no greater risk of reaction posed for those without an allergy.
FDA Approves Spark Therapeutics' Voretigene Neparvovec-rzyl
This is the first gene therapy approved in the US targeting mutations in a specific gene.
FDA Approves New HIV VITROS Combo Test
The new test expands infectious disease examination and shortens the diagnostic window.
Pfizer Initiates Phase 3 PF-04965842 Program for Atopic Dermatitis
Based off positive phase 2b trial results, phase 3 will evaluate the safety and efficacy of PF-04965842.
Alternative Method to Treat Recurrent Clostridium Difficile
FMT delivered by capsules were shown to be 96.2% effective, the same success rate as delivered by colonoscopy.
Parents Submit Smartphone Photos Offering Accurate Teledermatology Diagnoses
About 83% of the time a photograph-based diagnosis matched the in-person diagnosis.
FDA Accepts BLA for Galcanezumab for Migraine Prevention
Data from 3 phase 3 studies demonstrates a significant decrease in the average number of monthly migraine headache days.
2017 Brings More Possible Treatment Options for AD Patients
This year the Alzheimer's space has seen several drugs undergo phase 3 clinical trials.
Akili Achieves Primary Efficacy Endpoint in ADHD Trial
The first-of-its-kind prescription digital medicine video game plans for regulatory filing in the first half of 2018.
Physician Ratings Lowered When Patient Requests Denied
Communications training may allow doctors to effectively respond to patient requests for unnecessary tests and treatments.
Gilead Announces 10-Year Commitment to Address HIV/AIDS
New initiative encourages communities to implement proactive solutions.
Risankizumab Shows Positive Results for Plaque Psoriasis
Nearly half of the study participants achieved complete skin at week 16, while 87% maintained the response at week 52.
FDA Approves Ixekizumab for Psoriatic Arthritis
PsA is the second approved indication for Taltz in the US.
Migraines Linked to High Sodium Levels in Cerebrospinal Fluids
Sodium concentrations were significantly higher in the brain’s cerebrospinal fluid in migraine patients.
Secukinumab First Biologic to Show Efficacy in Nail, Palmoplantar Psoriasis
This is the first time a biologic demonstrated long-term efficacy and safety in nail and palmoplantar psoriasis.
Combination HIV Prevention Reduces Infections
The study in Uganda suggests the global effort to eradicate HIV in high-risk populations is working.
FDA Approves EKG Reader for Apple Watch
The smart strap is the first medical accessory for a smartwatch to receive FDA approval.
Advancements and Challenges in Global Abortion Safety
Simple tech is making safe abortions possible at the primary care level, but unsafe abortions persist worldwide.
FMT Capsules Noninferior to Colonoscopy in Preventing RCDI
A capsule containing frozen donor bacteria was shown to be 96% effective in treating C. diff.